2017 AHA / ACC Update on 2014 Valvular Disease Q6

Symptomatic Severe MR

According to the
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease Failure

“Mitral valve surgery is recommended for symptomatic patients with chronic severe primary MR (stage D) and ____________”

a) LVEF less than 30%
b) LVEF greater than 30%
c) LVEF less than 45%
d) LVEF greater than 45%

click here for answer

(B)

“Mitral valve surgery is recommended for symptomatic
patients with chronic severe primary MR (stage D) and
LVEF greater than 30% (73–75).”

Leave Comment

Your email address will not be published. Required fields are marked *